ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Communications

Topics

Biology

Cancer Oncology

Molecular Biology

Mutation

Synthetic Lethality

Show all topics

DOI

10.1038/ncomms13837

License

CC-BY

Other Formats

PDF